378 related articles for article (PubMed ID: 20636872)
1. Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water soluble drugs I. Phase behaviour in physiologically-relevant media.
Nguyen TH; Hanley T; Porter CJ; Larson I; Boyd BJ
J Pharm Pharmacol; 2010 Jul; 62(7):844-55. PubMed ID: 20636872
[TBL] [Abstract][Full Text] [Related]
2. Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water-soluble drugs II. In-vivo evaluation.
Nguyen TH; Hanley T; Porter CJ; Larson I; Boyd BJ
J Pharm Pharmacol; 2010 Jul; 62(7):856-65. PubMed ID: 20636873
[TBL] [Abstract][Full Text] [Related]
3. In Vivo Formation of Cubic Phase in Situ after Oral Administration of Cubic Phase Precursor Formulation Provides Long Duration Gastric Retention and Absorption for Poorly Water-Soluble Drugs.
Pham AC; Hong L; Montagnat O; Nowell CJ; Nguyen TH; Boyd BJ
Mol Pharm; 2016 Jan; 13(1):280-6. PubMed ID: 26567591
[TBL] [Abstract][Full Text] [Related]
4. Nanostructured liquid crystalline particles provide long duration sustained-release effect for a poorly water soluble drug after oral administration.
Nguyen TH; Hanley T; Porter CJ; Boyd BJ
J Control Release; 2011 Jul; 153(2):180-6. PubMed ID: 21497623
[TBL] [Abstract][Full Text] [Related]
5. A lipid-based liquid crystalline matrix that provides sustained release and enhanced oral bioavailability for a model poorly water soluble drug in rats.
Boyd BJ; Khoo SM; Whittaker DV; Davey G; Porter CJ
Int J Pharm; 2007 Aug; 340(1-2):52-60. PubMed ID: 17467935
[TBL] [Abstract][Full Text] [Related]
6. Liquid crystalline systems of phytantriol and glyceryl monooleate containing a hydrophilic protein: Characterisation, swelling and release kinetics.
Rizwan SB; Hanley T; Boyd BJ; Rades T; Hook S
J Pharm Sci; 2009 Nov; 98(11):4191-204. PubMed ID: 19340889
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the link between self-assembled mesophase structure and drug release.
Phan S; Fong WK; Kirby N; Hanley T; Boyd BJ
Int J Pharm; 2011 Dec; 421(1):176-82. PubMed ID: 21963475
[TBL] [Abstract][Full Text] [Related]
8. Nanostructure of liquid crystalline matrix determines in vitro sustained release and in vivo oral absorption kinetics for hydrophilic model drugs.
Lee KW; Nguyen TH; Hanley T; Boyd BJ
Int J Pharm; 2009 Jan; 365(1-2):190-9. PubMed ID: 18790030
[TBL] [Abstract][Full Text] [Related]
9. Examining the gastrointestinal transit of lipid-based liquid crystalline systems using whole-animal imaging.
Pham AC; Nguyen TH; Nowell CJ; Graham B; Boyd BJ
Drug Deliv Transl Res; 2015 Dec; 5(6):566-74. PubMed ID: 26328930
[TBL] [Abstract][Full Text] [Related]
10. Stimuli responsive liquid crystals provide 'on-demand' drug delivery in vitro and in vivo.
Fong WK; Hanley T; Boyd BJ
J Control Release; 2009 May; 135(3):218-26. PubMed ID: 19331865
[TBL] [Abstract][Full Text] [Related]
11. Bulk and dispersed aqueous phase behavior of phytantriol: effect of vitamin E acetate and F127 polymer on liquid crystal nanostructure.
Dong YD; Larson I; Hanley T; Boyd BJ
Langmuir; 2006 Nov; 22(23):9512-8. PubMed ID: 17073473
[TBL] [Abstract][Full Text] [Related]
12. Solubilisation behaviour of poorly water-soluble drugs during digestion of solid SMEDDS.
Vithani K; Hawley A; Jannin V; Pouton C; Boyd BJ
Eur J Pharm Biopharm; 2018 Sep; 130():236-246. PubMed ID: 29981444
[TBL] [Abstract][Full Text] [Related]
13. A novel cubic phase of medium chain lipid origin for the delivery of poorly water soluble drugs.
Kossena GA; Charman WN; Boyd BJ; Porter CJ
J Control Release; 2004 Sep; 99(2):217-29. PubMed ID: 15380632
[TBL] [Abstract][Full Text] [Related]
14. Impurities in commercial phytantriol significantly alter its lyotropic liquid-crystalline phase behavior.
Dong YD; Dong AW; Larson I; Rappolt M; Amenitsch H; Hanley T; Boyd BJ
Langmuir; 2008 Jun; 24(13):6998-7003. PubMed ID: 18522450
[TBL] [Abstract][Full Text] [Related]
15. Phytantriol-based inverted type bicontinuous cubic phase for vascular embolization and drug sustained release.
Han K; Pan X; Chen M; Wang R; Xu Y; Feng M; Li G; Huang M; Wu C
Eur J Pharm Sci; 2010 Dec; 41(5):692-9. PubMed ID: 20883779
[TBL] [Abstract][Full Text] [Related]
16. Drug release from lipid liquid crystalline phases: relation with phase behavior.
Costa-Balogh FO; Sparr E; Sousa JJ; Pais AC
Drug Dev Ind Pharm; 2010 Apr; 36(4):470-81. PubMed ID: 19848561
[TBL] [Abstract][Full Text] [Related]
17. Liquid Crystalline Systems Based on Glyceryl Monooleate and Penetration Enhancers for Skin Delivery of Celecoxib: Characterization, In Vitro Drug Release, and In Vivo Studies.
Dante MCL; Borgheti-Cardoso LN; Fantini MCA; Praça FSG; Medina WSG; Pierre MBR; Lara MG
J Pharm Sci; 2018 Mar; 107(3):870-878. PubMed ID: 29108729
[TBL] [Abstract][Full Text] [Related]
18. Transfer of lipid and phase reorganisation in self-assembled liquid crystal nanostructured particles based on phytantriol.
Tilley A; Dong YD; Amenitsch H; Rappolt M; Boyd BJ
Phys Chem Chem Phys; 2011 Feb; 13(8):3026-32. PubMed ID: 21240427
[TBL] [Abstract][Full Text] [Related]
19. Comparative studies on glycerol monooleate- and phytantriol-based cubosomes containing oridonin in vitro and in vivo.
Shi X; Peng T; Huang Y; Mei L; Gu Y; Huang J; Han K; Li G; Hu C; Pan X; Wu C
Pharm Dev Technol; 2017 May; 22(3):322-329. PubMed ID: 26670780
[TBL] [Abstract][Full Text] [Related]
20. Novel spiropyran amphiphiles and their application as light-responsive liquid crystalline components.
Tangso KJ; Fong WK; Darwish T; Kirby N; Boyd BJ; Hanley TL
J Phys Chem B; 2013 Sep; 117(35):10203-10. PubMed ID: 23909814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
